YIDU TECH (02158) has repurchased over 42 million Hong Kong dollars for three consecutive days, and the main operation of Beijing Puhui Health Insurance has exceeded 4.5 million participating policies.
On January 28, iFlytek Technology (02158) again announced a share buyback, stating that it would repurchase 204,000 shares at a price of approximately HK$6 per share on that day, costing approximately HK$1.23 million.
On January 28, YIDU TECH (02158) once again announced a share buyback announcement, stating that it would repurchase 204,000 shares at a price of approximately 6 Hong Kong dollars per share on the same day, costing about 1.23 million Hong Kong dollars. Up to now, the company has implemented buyback operations intensively for three consecutive trading days, repurchasing a total of approximately 709,000 shares at a cumulative cost of over 4.2 million Hong Kong dollars, continuing to demonstrate its recognition of the company's intrinsic value and confidence in long-term development with real money.
In addition to the active actions on the capital side, there have been developments in the company's main business. The number of insured participants in the 2026 Beijing Universal Health Insurance project, the main operation of the company, has exceeded 4.5 million. As the enterprise that has served as the main operating platform for this project for five consecutive years, YIDU TECH has continuously assisted in the construction of a multi-level medical security system in the capital with professional operation services and technological empowerment, further demonstrating its business strength and market recognition.
Earlier reports show that the founder and chairman of YIDU TECH, Gong Rujing, was recently invited to attend the 2026 Davos Winter Forum. During the forum, a tripartite cooperation announcement was made by the Novartis Foundation, Brunei Ministry of Health, and the company's subsidiary EVYD company, stating that they would jointly implement the CARDIO4Cities project, which is driven by artificial intelligence for the prevention and control of cardiovascular diseases, to further expand international cooperation. At the same time, the authoritative industry ranking "2025 Medical Big Data Enterprise Ranking" was officially announced, with YIDU TECH securing the top spot for the seventh consecutive year, leading the way in the medical big data field with its deep technological accumulation, mature product system, and rich industry experience.
Related Articles
.png)
THE LLOY DEV (01546) changes ownership, World Nexus will resume trading on January 29th.

OSL GROUP (00863) granted a total of 5,428,770 shares of bonus shares.

CF PHARMTECH (02652) spent approximately 532,900 Hong Kong dollars to repurchase 15,000 shares on January 28th.
THE LLOY DEV (01546) changes ownership, World Nexus will resume trading on January 29th.
.png)
OSL GROUP (00863) granted a total of 5,428,770 shares of bonus shares.

CF PHARMTECH (02652) spent approximately 532,900 Hong Kong dollars to repurchase 15,000 shares on January 28th.

RECOMMEND

New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026

117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026

“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026


